Please try another search
Technical synergies between xPloration, OmniFlic ®, OmniClic ® and OmniDeep ®enable new bispecific antibody discovery workflows for OmniAb's partners EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb,...
OmniAb Inc. (Ticker: OABI) has disclosed its financial results for the first quarter of 2024, reporting revenue of $3.8 million and a net loss of $19 million. Despite the loss, the company has shown...
EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in five investor conferences during the month of May.RBC Capital Markets...
Instrument Type
Region
Sector
Industry
Date
Category
Provider